TUBB4A-related leukodystrophy
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
TUBB4A-related leukodystrophy is a disorder that affects the nervous system. Leukodystrophies are conditions that involve abnormalities of the nervous system's white matter, which consists of nerve fibers covered by a fatty substance called myelin. Myelin insulates nerve fibers and promotes the rapid transmission of nerve impulses. In particular, TUBB4A-related leukodystrophy involves hypomyelination, which means that the nervous system has a reduced ability to form myelin. In some affected individuals, myelin may also break down, which is known as demyelination.
Video picks for Genetic conditionsVideo library
Description
TUBB4A-related leukodystrophy is a disorder that affects the nervous system. Leukodystrophies are conditions that involve abnormalities of the nervous system's white matter, which consists of nerve fibers covered by a fatty substance called myelin. Myelin insulates nerve fibers and promotes the rapid transmission of nerve impulses. In particular, TUBB4A-related leukodystrophy involves hypomyelination, which means that the nervous system has a reduced ability to form myelin. In some affected individuals, myelin may also break down, which is known as demyelination.
People with TUBB4A-related leukodystrophy have different combinations of signs and symptoms. Some of these combinations are described as separate disorders. However, the features in some affected individuals do not fit into these defined disorders. Researchers now group all of these cases of leukodystrophy, which have the same genetic cause, as TUBB4A-related leukodystrophy.
At the most severe end of the TUBB4A-related leukodystrophy spectrum is a condition called hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC). This disorder begins in infancy or early childhood. Most affected individuals have delayed development of motor skills, such as sitting and walking, and some are never able to walk on their own. In other cases, motor skills develop normally and then are lost in early childhood (developmental regression). In addition, individuals with H-ABC have other movement abnormalities, such as involuntary muscle contractions (dystonia), uncontrolled movements of the limbs (choreoathetosis), muscle stiffness (rigidity), and difficulty coordinating movements (ataxia). These individuals also often have impaired speech (dysarthria), a weak voice (dysphonia), and swallowing problems (dysphagia). Some develop seizures. Learning difficulty is common in individuals with H-ABC.
H-ABC is characterised by particular brain abnormalities, including hypomyelination. In addition, tissue in certain regions of the brain breaks down (atrophies), most prominently in a region called the putamen, which is part of a group of structures that help control movement (the basal ganglia). Atrophy of brain tissue in another region involved in movement called the cerebellum is common, and atrophy of the cerebrum, which controls most voluntary activity, language, sensory perception, learning, and memory, can also occur.
At the mildest end of the TUBB4A-related leukodystrophy spectrum is a condition called isolated hypomyelination, which begins at any time from late childhood to adulthood. Individuals at this end of the spectrum have mild hypomyelination and sometimes mild atrophy of the cerebellum, but no problems with the basal ganglia. These individuals can have movement problems, dysarthria, and learning difficulty, although these features are typically milder than in H-ABC.
The features in other individuals with TUBB4A-related leukodystrophy fall in between these two extremes. Affected individuals can have varying degrees of hypomyelination and atrophy or impairment of the basal ganglia or other brain regions. Movement problems can also occur. A small group of affected individuals develop muscle stiffness and paralysis of the lower limbs (spastic paraplegia) that slowly worsen. In addition, these individuals may have mild hypomyelination and ataxia without the other movement or learning problems common in H-ABC.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
TUBB4A-associated hypomyelinating leukoencephalopathies
TUBB4A-related hypomyelinating leukodystrophy
Patient picks for Genetic conditions

Chest and lungs
Tuberculosis
Tuberculosis (TB) is an infection with a germ (bacterium) called Mycobacterium tuberculosis. If you have symptoms, or a doctor can find signs of the infection when examining you, this is known as active tuberculosis. If you have TB infection without any signs or symptoms, this is known as latent TB.
by Dr Colin Tidy, MRCGP

General health
Asbestos-related diseases
People exposed to asbestos can develop diseases in later life. These most commonly affect the lungs but can also affect the lining of the tummy (abdomen). Some conditions - for example, mesothelioma or lung cancer - are more serious than others. This leaflet gives a brief overview of the diseases that are related to having an exposure to asbestos in the past.
by Dr Louise Newson, MRCGP

Travel and vaccinations
Ebola
Ebola is a viral infection, which mainly occurs in West and Equatorial Africa. There is as yet no vaccine or cure for Ebola, and about 4 out of 10 of those infected die of the disease. The risk of becoming infected with Ebola in the UK is very small. Ebola is spread by close contact with an infected person. People with Ebola become infectious when they have symptoms.
by Dr Mary Elisabeth Lowth, FRCGP

Chest and lungs
SARS and MERS virus
Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) are viral infections. Both infections can cause very serious illnesses that particularly affect the lungs. SARS caused many infections, especially in Asia, in 2002-2004 but was not heard of for some time. A SARS-CoV-2 (COVID-19) outbreak emerged in Wuhan, China in December 2019. This spread rapidly and was declared a global pandemic in 2020. MERS was first recognised in the Middle East in 2012. Most of the initial infections were in the Middle East. However, by February 2018, the World Health Organization (WHO) had reported cases in many other countries.
by Dr Hayley Willacy, FRCGP

Travel and vaccinations
Roundworms
Roundworms (also called nematodes) are worms with a long round body. They vary in length from several millimetres to up to two metres. Roundworms are common in warm tropical countries and most infections seen in the UK will have been acquired abroad. Children are more often affected than adults. Treatment is usually very effective but wiping out (eradication of) roundworm infections has proved to be very difficult.
by Dr Toni Hazell, FRCGP

Infections
Leptospirosis and Weil's disease
Leptospirosis is caused by infection with Leptospira germs (bacteria). The infection passes from animals (commonly rats, cattle, pigs and dogs) to humans. In most cases, leptospirosis causes a mild illness. But, in some people, a more severe illness occurs. This more severe form is commonly referred to as Weil's disease. The main treatment for leptospirosis is antibiotics and most people make a full recovery.
by Dr Caroline Wiggins, MRCGP
Related patient information and medicines

Patient information leaflet
Tuberculosis
AIDS HIV and AIDs (TB is common in people with AIDS). The num... What other tuberculosis bacteria exist. As mentioned above, the disease that we call 'tuberculosis', or 'TB', is caused by a bacterium called Mycobacterium tuberculosis. Depending on which part of the body is affected, various symptoms may then occur: Lymph glands - you may have a.

Patient information leaflet
Smoking
Cigarette smoking is the greatest single cause of illness and premature death in the UK. Worldwide, tobacco kills 7 million people every year. Almost a million deaths are due to non-smokers being exposed to second-hand smoke. This leaflet explains why smoking tobacco is so harmful. It also lists the benefits of stopping, and how to get help to.

Patient information leaflet
Asbestos-related diseases
People exposed to asbestos can develop diseases in later life. These most commonly affect the lungs but can also affect the lining of the tummy (abdomen). Some conditions - for example, mesothelioma or lung cancer - are more serious than others. This leaflet gives a brief overview of the diseases that are related to having an exposure to asbestos.

Patient information leaflet
Can I take Mirabegron and Rivaroxaban together?
Taking these two medicines together is generally considered sa... Why this happens Mirabegron Mirabegron for urinary symptoms and rivaroxaban Rivaroxaban tablets are processed by different pathways in the body. Mirabegron is primarily broken down by enzymes called CYP3A4 and CYP2D6, while rivaroxaban is processed by CYP3A4 and a transport protein.

Patient information leaflet
Ebola
Ebola is a viral infection, which mainly occurs in West and Equatorial Africa. There is as yet no vaccine or cure for Ebola, and about 4 out of 10 of those infected die of the disease. The risk of becoming infected with Ebola in the UK is very small. Ebola is spread by close contact with an infected person. People with Ebola become infectious when.

Patient information leaflet
Can I take Collagen and Tamoxifen together?
Ou... Simply search for your medicines to see potential interactions and what to do about them. Disclaimer This information is for general educational purposes only and should not be relied upon as a substitute for professional medical advice. Always consult your GP, pharmacist, or another qualified healthcare professional before making decisions.
Further reading and references
- TUBB4A-related leukodystrophy; MedlinePlus, National Library of Medicine.
- Blumkin L, Halevy A, Ben-Ami-Raichman D, Dahari D, Haviv A, Sarit C, Lev D, van der Knaap MS, Lerman-Sagie T, Leshinsky-Silver E. Expansion of the spectrum of TUBB4A-related disorders: a new phenotype associated with a novel mutation in the TUBB4A gene. Neurogenetics. 2014 May;15(2):107-13. doi: 10.1007/s10048-014-0392-2. Epub 2014 Feb 14.
- Gavazzi F, Pizzino A, Bally JF, Fraser J, Simons C, Wolf NI, van der Knaap M, Vanderver A. TUBB4A-Related Neurologic Disorders. 2016 Nov 3 [updated 2026 Mar 5]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK395611/
- Hamilton EM, Polder E, Vanderver A, Naidu S, Schiffmann R, Fisher K, Raguz AB, Blumkin L; H-ABC Research Group; van Berkel CG, Waisfisz Q, Simons C, Taft RJ, Abbink TE, Wolf NI, van der Knaap MS. Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype-phenotype correlation. Brain. 2014 Jul;137(Pt 7):1921-30. doi: 10.1093/brain/awu110. Epub 2014 Apr 30.
- Kancheva D, Chamova T, Guergueltcheva V, Mitev V, Azmanov DN, Kalaydjieva L, Tournev I, Jordanova A. Mosaic dominant TUBB4A mutation in an inbred family with complicated hereditary spastic paraplegia. Mov Disord. 2015 May;30(6):854-8. doi: 10.1002/mds.26196. Epub 2015 Mar 15.
- Miyatake S, Osaka H, Shiina M, Sasaki M, Takanashi J, Haginoya K, Wada T, Morimoto M, Ando N, Ikuta Y, Nakashima M, Tsurusaki Y, Miyake N, Ogata K, Matsumoto N, Saitsu H. Expanding the phenotypic spectrum of TUBB4A-associated hypomyelinating leukoencephalopathies. Neurology. 2014 Jun 17;82(24):2230-7. doi: 10.1212/WNL.0000000000000535. Epub 2014 May 21.
- Pizzino A, Pierson TM, Guo Y, Helman G, Fortini S, Guerrero K, Saitta S, Murphy JL, Padiath Q, Xie Y, Hakonarson H, Xu X, Funari T, Fox M, Taft RJ, van der Knaap MS, Bernard G, Schiffmann R, Simons C, Vanderver A. TUBB4A de novo mutations cause isolated hypomyelination. Neurology. 2014 Sep 2;83(10):898-902. doi: 10.1212/WNL.0000000000000754. Epub 2014 Aug 1.
- Simons C, Wolf NI, McNeil N, Caldovic L, Devaney JM, Takanohashi A, Crawford J, Ru K, Grimmond SM, Miller D, Tonduti D, Schmidt JL, Chudnow RS, van Coster R, Lagae L, Kisler J, Sperner J, van der Knaap MS, Schiffmann R, Taft RJ, Vanderver A. A de novo mutation in the beta-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum. Am J Hum Genet. 2013 May 2;92(5):767-73. doi: 10.1016/j.ajhg.2013.03.018. Epub 2013 Apr 11.
- Tonduti D, Aiello C, Renaldo F, Dorboz I, Saaman S, Rodriguez D, Fettah H, Elmaleh M, Biancheri R, Barresi S, Boccone L, Orcesi S, Pichiecchio A, Zangaglia R, Maurey H, Rossi A, Boespflug-Tanguy O, Bertini E. TUBB4A-related hypomyelinating leukodystrophy: New insights from a series of 12 patients. Eur J Paediatr Neurol. 2016 Mar;20(2):323-330. doi: 10.1016/j.ejpn.2015.11.006. Epub 2015 Nov 28.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

